STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #232 by analyst upside · 2026-08-12
SINT
Sintx Technologies, Inc.
Healthcare · Market Cap $11M · P/E 0x
ANALYST PRICE TARGET
+415.5%
implied upside to consensus target
Current Price $1.77
Consensus Target $9.12
Bull Target $12.0
Bear Target $6.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
3
Hold
0
Sell
0
52-Week Low $1.4
52-Week High $6.78
YTD Return -53.2%
FUNDAMENTALS
Market Cap $11M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-5.57
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $1M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.4
52-Week High $6.78
Current Price $1.77
Bear Target $6.0
Bull Target $12.0
● Now $1.77 ● Target $9.12
TRADING DATA
Avg Volume 105K
YTD Return -53.2%
Analyst Count 4
Consensus Buy
Upside to Target +415.5%
Last Updated 2026-08-12

ANALYST SUMMARY

Sintx Technologies, Inc. (SINT) is currently trading at $1.77 with a Wall Street consensus price target of $9.12, implying potential upside of 415.5% over the next 12 months. 4 analysts currently cover SINT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $12.0, while the most cautious has a target of $6.0.

SINT operates in the Healthcare sector with a market capitalisation of $11M. The stock is down 53.2% year-to-date and is currently trading near the lower end of its 52-week range of $1.4 – $6.78.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SINT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. reit
Buy → Buy 2026-05-20 31% win rate (48 calls)
HC Wainwright & Co. ● Initiated
Buy 2026-04-13 31% win rate (48 calls)
Ascendiant Capital - Reiterated
Buy → Buy 2026-04-08 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-12-08 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-09-22 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-05-30 Building track record
Ascendiant Capital - Reiterated
Buy → Buy 2025-04-21 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →